These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tamoxifen-induced endometrial polyp. A case report and review of the literature. Nomikos IN; Elemenoglou J; Papatheophanis J Eur J Gynaecol Oncol; 1998; 19(5):476-8. PubMed ID: 9863916 [TBL] [Abstract][Full Text] [Related]
5. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510 [TBL] [Abstract][Full Text] [Related]
6. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Chin J; Konje JC; Hickey M Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400 [TBL] [Abstract][Full Text] [Related]
8. Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer. Timmerman D; Deprest J; Verbesselt R; Moerman P; De Brabanter J; Vergote I Eur J Cancer; 2000 Sep; 36 Suppl 4():S40-2. PubMed ID: 11056312 [TBL] [Abstract][Full Text] [Related]
10. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer. Barakat RR J Clin Oncol; 1999 Jul; 17(7):1967-8. PubMed ID: 10561245 [No Abstract] [Full Text] [Related]
11. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892 [TBL] [Abstract][Full Text] [Related]
12. Tamoxifen, screening and new oestrogen receptor modulators. Neven P; Vergote I Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):365-80. PubMed ID: 11476559 [TBL] [Abstract][Full Text] [Related]
13. Overview of studies on endometrial cancer and other types of cancer in humans: perspectives of an epidemiologist. MacMahon B Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-122-S1-39. PubMed ID: 9045310 [TBL] [Abstract][Full Text] [Related]
14. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related]
15. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800 [TBL] [Abstract][Full Text] [Related]
16. The effect of tamoxifen on the endometrium. Barakat RR Oncology (Williston Park); 1995 Feb; 9(2):129-34; discussion 139-40, 142. PubMed ID: 8771096 [TBL] [Abstract][Full Text] [Related]
17. Iatrogenic endometrial megapolyps in women with breast carcinoma. Berezowsky J; Chalvardjian A; Murray D Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466 [TBL] [Abstract][Full Text] [Related]
18. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Corley D; Rowe J; Curtis MT; Hogan WM; Noumoff JS; Livolsi VA Obstet Gynecol; 1992 Jan; 79(1):111-6. PubMed ID: 1727568 [TBL] [Abstract][Full Text] [Related]